Practice Guidelines

Cancer Screening: ACS Releases Annual Summary of Recommendations

Am Fam Physician. 2019;99(11):719-722. 

In This Article

Cervical Cancer

An estimated 13,240 persons will be diagnosed with invasive cervical cancer in 2018, with an associated 4,170 deaths. The ACS, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology recommendations for screening are based on age, history of screening, and available screening options. Currently, the guidelines address screening women 21 to 65 years of age and 65 years or older who are at average risk of cervical cancer, recommending that women younger than 21 years not be screened regardless of any risk factors or sexual history. They also address the human papillomavirus (HPV) vaccine and other special considerations. The current guidelines recommend that women with atypical squamous cells of undetermined significance that were found to be negative for HPV should have repeat screening in three years. The recommendations on atypical squamous cells of undetermined significance and HPV vaccines have been added since the 2012 guideline, and a full update of the cervical cancer screening guidelines is currently being completed.